1. Home
  2. OWLT vs MGNX Comparison

OWLT vs MGNX Comparison

Compare OWLT & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OWLT
  • MGNX
  • Stock Information
  • Founded
  • OWLT 2013
  • MGNX 2000
  • Country
  • OWLT United States
  • MGNX United States
  • Employees
  • OWLT N/A
  • MGNX N/A
  • Industry
  • OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OWLT Health Care
  • MGNX Health Care
  • Exchange
  • OWLT Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • OWLT 73.9M
  • MGNX 70.3M
  • IPO Year
  • OWLT N/A
  • MGNX 2013
  • Fundamental
  • Price
  • OWLT $3.24
  • MGNX $1.26
  • Analyst Decision
  • OWLT
  • MGNX Hold
  • Analyst Count
  • OWLT 0
  • MGNX 10
  • Target Price
  • OWLT N/A
  • MGNX $6.83
  • AVG Volume (30 Days)
  • OWLT 44.9K
  • MGNX 1.1M
  • Earning Date
  • OWLT 05-05-2025
  • MGNX 05-08-2025
  • Dividend Yield
  • OWLT N/A
  • MGNX N/A
  • EPS Growth
  • OWLT N/A
  • MGNX N/A
  • EPS
  • OWLT N/A
  • MGNX N/A
  • Revenue
  • OWLT $78,056,000.00
  • MGNX $149,962,000.00
  • Revenue This Year
  • OWLT $16.98
  • MGNX N/A
  • Revenue Next Year
  • OWLT $22.85
  • MGNX $80.86
  • P/E Ratio
  • OWLT N/A
  • MGNX N/A
  • Revenue Growth
  • OWLT 44.52
  • MGNX 155.26
  • 52 Week Low
  • OWLT $2.75
  • MGNX $0.99
  • 52 Week High
  • OWLT $5.65
  • MGNX $17.24
  • Technical
  • Relative Strength Index (RSI)
  • OWLT 37.74
  • MGNX 34.84
  • Support Level
  • OWLT $3.12
  • MGNX $1.10
  • Resistance Level
  • OWLT $3.57
  • MGNX $1.34
  • Average True Range (ATR)
  • OWLT 0.37
  • MGNX 0.13
  • MACD
  • OWLT 0.01
  • MGNX 0.04
  • Stochastic Oscillator
  • OWLT 40.50
  • MGNX 77.14

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: